9 Treatment Tiers for Genitourinary Syndrome of Menopause That Go Far Beyond Lubricants
The thing nobody warned me about GSM is how quietly it arrives — a little dryness here, some discomfort there — until one day it's affecting intimacy, bladder habits, and basic comfort all at once. It took me far too long to learn that lubricants, while helpful, are the bottom rung of a very tall ladder, and that the options further up that ladder are genuinely life-changing.
Learn more about Rose →Over-the-Counter Vaginal Lubricants
Water-based and silicone-based lubricants reduce friction during sexual activity but do nothing to reverse the underlying tissue changes caused by estrogen loss. They work in the moment — think of them as symptom management, not treatment. Women with mild, infrequent discomfort may find this tier sufficient, but those with daily dryness or tissue fragility almost always need more.
Regular Vaginal Moisturizers
Unlike lubricants, non-hormonal vaginal moisturizers (typically containing polycarbophil, hyaluronic acid, or glycogen-based formulas) are used every 2–3 days to maintain baseline hydration in vaginal tissue. Clinical trials show they meaningfully reduce dryness and itching scores compared with placebo, though they don't restore tissue architecture the way estrogen does. This tier is a legitimate long-term strategy for women who cannot or choose not to use hormones.
Vaginal pH Correction
Estrogen loss raises vaginal pH from the healthy acidic range (3.8–4.5) toward a more alkaline environment, which disrupts the lactobacillus-dominant microbiome and increases susceptibility to infections and odor. Boric acid suppositories and acidifying gels can temporarily restore pH balance and reduce associated symptoms. This tier is often useful as a bridge or complement to other treatments, particularly for women dealing with recurrent bacterial vaginosis alongside GSM.
Pelvic Floor Physical Therapy
When GSM leads to painful penetration, the body often responds by tensing the pelvic floor muscles — a protective reflex that quickly becomes its own problem, layering hypertonic dysfunction on top of tissue changes. A specialist pelvic floor physiotherapist can address muscular guarding, connective tissue restrictions, and scar tissue through internal and external manual techniques. Evidence supports this approach for dyspareunia specifically, and it is frequently underused as a first-line referral.
Low-Dose Vaginal Estrogen
This is the most evidence-backed and most underused tier — a local estrogen delivered via cream, ring, or tablet directly to vaginal and urethral tissue. Because systemic absorption is minimal at low doses, it is considered appropriate for most women including many breast cancer survivors (with oncologist guidance), and it actually reverses tissue atrophy rather than just masking symptoms. International menopause guidelines consistently recommend this as first-line treatment for moderate-to-severe GSM, and the evidence base is extensive.
Vaginal DHEA (Prasterone)
Prasterone is an intravaginal suppository containing DHEA, a precursor hormone that vaginal cells convert locally into both estrogen and testosterone — making it useful for tissue health and sexual function simultaneously. Randomized controlled trials show improvements in dyspareunia, dryness, and sexual desire scores, and systemic hormone levels remain within normal postmenopausal ranges. It is a meaningful option for women who prefer to avoid direct estrogen prescriptions or who also want to address libido alongside tissue symptoms.
Ospemifene (Oral SERM)
Ospemifene is an oral selective estrogen receptor modulator that acts like estrogen in vaginal tissue while remaining neutral or mildly anti-estrogenic in breast tissue. It is taken as a daily pill — which some women prefer over intravaginal applications — and trials show significant improvement in vaginal dryness and dyspareunia over 12 weeks. It carries a small increased risk of venous thromboembolism and is not appropriate for women with a personal history of blood clots or estrogen-receptor-positive breast cancer.
Systemic Hormone Therapy
When a woman is also dealing with hot flushes, sleep disruption, mood changes, or joint pain alongside GSM, systemic MHT (menopausal hormone therapy) addresses the whole picture rather than managing each symptom in isolation. Systemic estrogen does reach vaginal tissue, though some women on systemic MHT still require supplemental vaginal estrogen for full GSM relief — both can be used together safely. This tier makes sense when GSM is one symptom among several rather than an isolated concern.
Energy-Based Devices (Laser and Radiofrequency)
Fractional CO2 laser and radiofrequency devices applied to vaginal tissue aim to stimulate collagen remodeling and improve tissue thickness, elasticity, and lubrication through a series of in-office treatments. Earlier studies showed promising results, but larger sham-controlled trials have produced more mixed findings, leading regulators in some countries to call for more rigorous evidence before widespread adoption. For women who cannot use hormones and have not responded adequately to non-hormonal options, these devices remain a reasonable conversation to have with a specialist — but they should not be positioned as a superior alternative to local estrogen.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.